N
CFMS

Nuveen’s Conformis, Inc. Common Stock CFMS Stock Holding History

Nuveen’s Portfolio CFMS Stock Details CFMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-21,099
Closed -$332K – 3398
2020
Q1 		$332K Sell
21,099
-83
-0.4% -$2.03K ﹤0.01% 2904
2019
Q4 		$795K Sell
21,182
-1,728
-8% -$81.9K ﹤0.01% 2768
2019
Q3 		$1.06M Buy
22,910
+9,334
+69% +$561K ﹤0.01% 2677
2019
Q2 		$1.48M Buy
+13,576
New +$1.12M ﹤0.01% 2573
2016
Q3 		– Sell
-3,425
Closed -$601K – 1445
2016
Q2 		$601K Sell
3,425
-4,437
-56% -$1.04M ﹤0.01% 1146
2016
Q1 		$2.11K Buy
7,862
+1,771
+29% +$469K 0.01% 724
2015
Q4 		$2.63K Buy
6,091
+117
+2% +$58.7K 0.01% 656
2015
Q3 		$2.7K Buy
+5,974
New +$3.01M 0.02% 648

Other funds holding CFMS

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Nuveen's CFMS Position: Q2 2020 in Review

Nuveen sold out of Conformis, Inc. Common Stock (CFMS) in Q2 2020, closing a stake of 21,099 shares — an estimated $332K sold.

Nuveen first reported a position in CFMS in Q3 2015 and held it in 8 quarters. The position peaked at $1.48M in Q2 2019. 68 funds tracked by Wall St. Rank hold CFMS as of Q2 2020.

  • Nuveen reported no remaining Conformis, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Nuveen sold 21,099 Conformis, Inc. Common Stock shares in Q2 2020, an estimated $332K.
  • Nuveen first reported a position in Conformis, Inc. Common Stock in Q3 2015 and held it in 8 quarters.
  • Nuveen's Conformis, Inc. Common Stock position peaked at $1.48M in Q2 2019.
  • 68 funds tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q2 2020.

Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.